A review of new treatments for inflammatory bowel disease, with a focus on clinical and endoscopic remission and precise molecular targeting of inflammatory cascades.
This paper presents the results of the CHARM trial that evaluated the efficacy and safety of adalimumab in the maintenance of response and remission in patients with moderate to severe Crohn’s disease. It includes references to earlier literature on the use of anti-tumour necrosis factor in inflammatory bowel disease.
This paper summarises the incidence and outcomes of acute severe colitis in a large cohort of patients diagnosed with ulcerative colitis.
This paper presents the results of a randomised trial of stem cell therapy in patients with complex perianal fistulas in Crohn’s disease.
This is the original study of infliximab in treatment of fistulas in Crohn’s disease.
Association of Coloproctology of Great Britain and Ireland consensus guidelines on surgery in inflammatory bowel disease.
British Society of Gastroenterology guidance on treatment of inflammatory bowel disease.
Asian Organization for Crohn’s and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.